Indeed, although the association between circulating adiponectin and cardiovascular morbidity and mortality is complex and may greatly depend on the health status of the investigated population (124), several studies demonstrated that low circulating adiponectin (total or high molecular weight) were independent predictors of incident metabolic syndrome or T2DM (125, 126). Here, ADIPOQ is linked to metabolic syndrome.